Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello CA, Saetta M.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):894-901. doi: 10.1164/rccm.200804-646OC. Epub 2008 Aug 14.

PMID:
18703789
2.

A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.

Polverino F, Baraldo S, Bazzan E, Agostini S, Turato G, Lunardi F, Balestro E, Damin M, Papi A, Maestrelli P, Calabrese F, Saetta M.

Am J Respir Crit Care Med. 2010 Oct 15;182(8):1011-9. doi: 10.1164/rccm.200911-1700OC. Epub 2010 Jun 25.

PMID:
20581172
3.

[Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].

Zhang JQ, Lao QF, Chu SY, Bai J, Zhong XN.

Zhonghua Yi Xue Za Zhi. 2010 May 25;90(20):1431-5. Chinese.

PMID:
20646637
4.

Increased expression of CD4+IL-17+ cells in the lung tissue of patients with stable chronic obstructive pulmonary disease (COPD) and smokers.

Zhang J, Chu S, Zhong X, Lao Q, He Z, Liang Y.

Int Immunopharmacol. 2013 Jan;15(1):58-66. doi: 10.1016/j.intimp.2012.10.018. Epub 2012 Nov 3.

PMID:
23127823
5.

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.

Ferhani N, Letuve S, Kozhich A, Thibaudeau O, Grandsaigne M, Maret M, Dombret MC, Sims GP, Kolbeck R, Coyle AJ, Aubier M, Pretolani M.

Am J Respir Crit Care Med. 2010 May 1;181(9):917-27. doi: 10.1164/rccm.200903-0340OC. Epub 2010 Feb 4.

PMID:
20133931
7.

[The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].

Wan P, Zhong XN, He ZY, Zhang JQ, Liu GN, Lao QF.

Zhonghua Nei Ke Za Zhi. 2009 Oct;48(10):841-5. Chinese.

PMID:
20079227
8.

Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.

Shaker SB, von Wachenfeldt KA, Larsson S, Mile I, Persdotter S, Dahlbäck M, Broberg P, Stoel B, Bach KS, Hestad M, Fehniger TE, Dirksen A.

Clin Respir J. 2008 Jan;2(1):17-25. doi: 10.1111/j.1752-699X.2007.00032.x.

PMID:
20298300
9.

The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.

Chu S, Zhong X, Zhang J, Lao Q, He Z, Bai J.

Int Immunopharmacol. 2011 Nov;11(11):1780-8. doi: 10.1016/j.intimp.2011.06.010. Epub 2011 Jul 23.

PMID:
21791252
11.

Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.

Rovina N, Dima E, Gerassimou C, Kollintza A, Gratziou C, Roussos C.

Respir Med. 2009 Jul;103(7):1056-62. doi: 10.1016/j.rmed.2009.01.011. Epub 2009 Feb 8.

12.

[Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].

Xiao W, Tong WL, Ma DD.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Nov;29(11):723-6. Chinese.

PMID:
17327049
13.

Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD.

de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS.

J Pathol. 2000 Apr;190(5):619-26.

PMID:
10727989
14.

Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.

Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, Bellettato CM, Papi A, Corbetta L, Zuin R, Sinigaglia F, Fabbri LM.

Am J Respir Crit Care Med. 2002 May 15;165(10):1404-9.

PMID:
12016104
15.

Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells.

Zhu J, Majumdar S, Qiu Y, Ansari T, Oliva A, Kips JC, Pauwels RA, De Rose V, Jeffery PK.

Am J Respir Crit Care Med. 2001 Dec 15;164(12):2220-8.

PMID:
11751191
17.

Impaired TNFalpha-induced VEGF expression in human airway smooth muscle cells from smokers with COPD: role of MAPkinases and histone acetylation--effect of dexamethasone.

Raidl M, Sibbing B, Strauch J, Müller K, Nemat A, Schneider PM, Hag H, Erdmann E, Koch A.

Cell Biochem Biophys. 2007;49(2):98-110.

PMID:
17906365
18.

Enhanced expression of human β-defensin 2 in peripheral lungs of patients with chronic obstructive pulmonary disease.

Liao Z, Dong J, Hu X, Wang T, Wan C, Li X, Li L, Guo L, Xu D, Wen F.

Peptides. 2012 Dec;38(2):350-6. doi: 10.1016/j.peptides.2012.09.013. Epub 2012 Sep 19.

PMID:
23000304
19.

Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease.

Zhang M, Li Q, Zhang XY, Ding X, Zhu D, Zhou X.

Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1487-93. doi: 10.1007/s10096-010-1027-7. Epub 2010 Aug 20.

PMID:
20725845
20.

Increased activation of p38 MAPK in COPD.

Renda T, Baraldo S, Pelaia G, Bazzan E, Turato G, Papi A, Maestrelli P, Maselli R, Vatrella A, Fabbri LM, Zuin R, Marsico SA, Saetta M.

Eur Respir J. 2008 Jan;31(1):62-9. Epub 2007 Oct 24.

Supplemental Content

Support Center